The Evolution of Oral Arsenic Trioxide: A Journey of Knowledge Exchange and Social Impact

In recent years, the development of oral arsenic trioxide has marked a significant milestone in the treatment of acute promyelocytic leukaemia (APL), a rare yet aggressive form of blood cancer.